Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pylori Duo as an Adjunctive Treatment for Helicobacter Pylori Infection
NCT07729293Not yet recruiting
- Sponsor
- Gala Servicios Clínicos
- Start
- Aug 2026
- Primary completion
- Oct 2027
- Countries
- 1
01
Overview
Randomised, double-blind trial in Helicobacter pylori infection (2 arms), sponsored by Gala Servicios Clínicos. Primary endpoint: Gastrointestinal adverse effects associated with standard eradication therapy up to 3 months. Planned start Aug 2026; status: not yet recruiting.
02
Conditions
Helicobacter pylori infection
Beyond the preview
Go deeper on NCT07729293.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07729293.